Skip to main content

Market Overview

Oramed Pharmaceuticals, Logitech International And Some Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Share:
Oramed Pharmaceuticals, Logitech International And Some Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session.

  • Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) shares dipped 70.3% to $3.19 in pre-market trading after the company reported Wednesday that its diabetes trial missed primary endpoint.
  • KNOT Offshore Partners LP (NYSE: KNOP) shares declined 30.7% to $7.27 in pre-market trading. The company’s board declared a quarterly cash distribution with respect to the quarter ended December 31, 2022, of $0.026 per common unit.
  • Logitech International S.A. (NASDAQ: LOGI) dropped 16.1% to $57.22 in pre-market trading after the company reported preliminary Q3 Results and cut FY23 outlook.

Don’t forget to check out our premarket coverage here

  • Kingsoft Cloud Holdings Limited (NASDAQ: KC) fell 5.8% to $4.37 in pre-market trading.
  • CureVac N.V. (NASDAQ: CVAC) shares fell 5.6% to $11.80 in pre-market trading.
  • AMTD IDEA Group (NYSE: AMTD) fell 4.7% to $1.63 in pre-market trading.
  • CS Disco, Inc. (NYSE: LAW) dropped 4.5% to $6.20 in pre-market trading.
  • The Necessity Retail REIT, Inc. (NASDAQ: RTL) dropped 3% to $6.05 in pre-market trading.

Now Read This: US Stocks End Sharply Higher, Market Volatility Increases

 

Related Articles (AMTD + CVAC)

View Comments and Join the Discussion!

Posted-In: big losersNews Penny Stocks Small Cap Pre-Market Outlook Markets Movers Trading Ideas Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com